0001214659-23-010919.txt : 20230809 0001214659-23-010919.hdr.sgml : 20230809 20230809163031 ACCESSION NUMBER: 0001214659-23-010919 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230809 FILED AS OF DATE: 20230809 DATE AS OF CHANGE: 20230809 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kraus Carl N CENTRAL INDEX KEY: 0001946475 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38599 FILM NUMBER: 231155664 MAIL ADDRESS: STREET 1: C/O ACERAGEN, INC. STREET 2: 15 TW ALEXANDER DRIVE CITY: DURHAM STATE: NC ZIP: 27709 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aquestive Therapeutics, Inc. CENTRAL INDEX KEY: 0001398733 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208623253 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 30 TECHNOLOGY DRIVE CITY: WARREN STATE: NJ ZIP: 07059 BUSINESS PHONE: 908-941-1900 MAIL ADDRESS: STREET 1: 30 TECHNOLOGY DRIVE CITY: WARREN STATE: NJ ZIP: 07059 FORMER COMPANY: FORMER CONFORMED NAME: MonoSol Rx, Inc. DATE OF NAME CHANGE: 20070507 4 1 marketforms-62126.xml PRIMARY DOCUMENT X0508 4 2023-08-09 0001398733 Aquestive Therapeutics, Inc. AQST 0001946475 Kraus Carl N C/O AQUESTIVE THERAPEUTICS, INC. 30 TECHNOLOGY DRIVE WARREN NJ 07059 false true false false Chief Medical Officer 0 Common Stock 2023-08-09 4 A false 150000 0 A 150000 D The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment /s/ Lori Braender, as Attorney-In-Fact 2023-08-09